Published in Blood on March 01, 1984
Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia. J Clin Invest (1987) 1.37
Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J Clin Invest (1985) 1.00
Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood (2000) 6.27
Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med (1995) 2.85
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol (2001) 2.71
Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON. Lancet (1992) 1.92
The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood (1999) 1.87
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler (2006) 1.70
Mutations in N-ras predominate in acute myeloid leukemia. Blood (1987) 1.68
Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene. Leukemia (2000) 1.64
Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward. J Clin Microbiol (1996) 1.61
Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia? Leukemia (1999) 1.44
[Diagnosis and treatment of non-Hodgkin lymphoma in Netherlands: variation in guidelines and in practice]. Ned Tijdschr Geneeskd (2000) 1.39
Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol (2001) 1.38
Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol (1993) 1.38
Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant (2005) 1.37
Characterization of a human multilineage-colony-stimulating factor cDNA clone identified by a conserved noncoding sequence in mouse interleukin-3. Gene (1987) 1.30
Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. Blood (1998) 1.29
Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci U S A (1994) 1.25
A method for cloning T-lymphocytic precursors in agar. Am J Hematol (1979) 1.20
Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. Emerg Infect Dis (2001) 1.19
Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes. Blood (1990) 1.18
TRIADs: a new class of proteins with a novel cysteine-rich signature. Protein Sci (1999) 1.16
STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene (2000) 1.16
Clonogenic cells in acute myeloblastic leukemia. Blood (1986) 1.16
Segmental uniparental disomy as a recurrent mechanism for homozygous CEBPA mutations in acute myeloid leukemia. Leukemia (2007) 1.16
Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. Blood (1996) 1.13
Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells. Blood (2000) 1.12
Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood (1997) 1.12
Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia (1997) 1.10
Application of myeloid growth factors in the treatment of acute myeloid leukemia. Leukemia (1997) 1.09
Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood (1990) 1.08
Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity. Blood (1996) 1.06
Somatostatin and the immune and haematopoetic system; a review. Eur J Clin Invest (1994) 1.04
The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML. Leukemia (2012) 1.02
Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia. Bone Marrow Transplant (2002) 0.99
Protein kinase C alpha controls erythropoietin receptor signaling. J Biol Chem (2000) 0.99
A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites. Nucleic Acids Res (1997) 0.98
Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur J Clin Invest (1992) 0.98
The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation. Blood (1996) 0.96
Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome. Blood (1997) 0.94
Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. Leukemia (1993) 0.94
Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro. Cancer Res (1978) 0.93
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. Br J Haematol (1999) 0.93
Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice. Leukemia (2000) 0.93
Effects of fibroblasts on the growth of erythroid progenitor cells in vitro. Exp Hematol (1977) 0.92
A characterization of T lymphocyte colony-forming cells (TL-CFC) in human bone marrow. Clin Exp Immunol (1980) 0.92
Stimulating spectrum of human recombinant multi-CSF (IL-3) on human marrow precursors: importance of accessory cells. Blood (1988) 0.92
Flow cytometric differential of leukocyte populations in normal bone marrow: influence of peripheral blood contamination. Cytometry B Clin Cytom (2008) 0.91
Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL. Leukemia (1988) 0.91
Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL). Bone Marrow Transplant (1995) 0.91
Human AML colony growth in serum-free culture. Leuk Res (1988) 0.89
Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia. Blood (1989) 0.89
Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis. Hematol J (2001) 0.89
Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor. Blood (1999) 0.89
MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia. Br J Haematol (1997) 0.88
Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes. J Clin Invest (1991) 0.88
Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neurosurg Psychiatry (2006) 0.88
ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells. Leukemia (2005) 0.88
Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage. Leukemia (1995) 0.88
Facilitated engraftment of human hematopoietic cells in severe combined immunodeficient mice following a single injection of Cl2MDP liposomes. Leukemia (1997) 0.87
Myelodysplastic syndromes standardized response criteria: further definition. Blood (2001) 0.87
Different stimulative effects of human bone marrow and fetal liver stromal cells on erythropoiesis in long-term culture. Blood (1987) 0.86
Conditions for engraftment of human acute myeloid leukemia (AML) in SCID mice. Leukemia (1995) 0.86
The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors. Blood (1987) 0.86
Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells. Leukemia (1994) 0.86
The incidence of herpes zoster in patients with Hodgkin's disease. An analysis of prognostic factors. Cancer (1985) 0.86
Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines. Br J Pharmacol (1998) 0.85
Influence of genetic resistance and silica particles on survival after bone marrow transplantation. Transplant Proc (1976) 0.85
Chronic myeloid leukemia with permanent disappearance of the Ph1 chromosome and development of new clonal subpopulations. Blood (1979) 0.85
PHA-induced colony formation in acute non-lymphocytic and chronic myeloid leukemia. Leuk Res (1980) 0.85
Common and pre-B acute lymphoblastic leukemia cells express interleukin 2 receptors, and interleukin 2 stimulates in vitro colony formation. Blood (1985) 0.85
Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells. Blood (1989) 0.85
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia? Bone Marrow Transplant (1999) 0.84
Modulation of colony stimulating factor-(CSF) dependent growth of acute myeloid leukemia by tumor necrosis factor. Leukemia (1990) 0.84
The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11. J Virol (1997) 0.84
Rapid clearance of cytomegalovirus-specific IgG after repeated intravenous infusions of human immunoglobulin into allogeneic bone marrow transplant recipients. J Infect Dis (1987) 0.83
Effects of human interleukin-3 on granulocytic colony-forming cells in human bone marrow. Blood (1989) 0.83
Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia. Blood (1996) 0.83
Selective ambulatory management of imported falciparum malaria: a 5-year prospective study. Eur J Clin Microbiol Infect Dis (2007) 0.83
Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand. Leukemia (1996) 0.83
Mutant Wilms' tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD). Leukemia (2009) 0.83
Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis. Rheumatol Int (1990) 0.82
Human recombinant multilineage colony stimulating factor (interleukin-3): stimulator of acute myelocytic leukemia progenitor cells in vitro. Blood (1987) 0.82
Protective effect of the bile salt hydrolase-active Lactobacillus reuteri against bile salt cytotoxicity. Appl Microbiol Biotechnol (2000) 0.82
[A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin]. Ned Tijdschr Geneeskd (1995) 0.82
Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia. Leukemia (1995) 0.82
Splenectomy for the treatment of thrombotic thrombocytopenic purpura. Br J Haematol (2005) 0.81
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia. Hematol J (2000) 0.81
Somatostatin analogue scintigraphy of malignant lymphomas. Br J Haematol (1993) 0.81